Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $104
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald maintains a Buy rating on Encompass Health (NYSE:EHC) and raises the price target from $100 to $104.
August 15, 2024 | 12:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities analyst David Macdonald maintains a Buy rating on Encompass Health and raises the price target from $100 to $104.
The Buy rating and increased price target from a reputable analyst at Truist Securities is likely to positively impact investor sentiment and drive short-term price appreciation for Encompass Health.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100